Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Randomized, Blinded, Placebo-controlled Study of the Safety and Efficacy of Natural Genome Reconstruction Technology of Hematopoietic Stem Cells in Adult Patients

NCT06877377 is registered in ClinicalTrials.gov with S.LAB (SOLOWAYS) as lead sponsor.

NCT NCT06877377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06877377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Randomized, Blinded, Placebo-controlled Study of the Safety and Efficacy of Natural Genome Reconstruction Technology of Hematopoietic Stem Cells in Adult Patients
Lead sponsor
S.LAB (SOLOWAYS)
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
March 1, 2026
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aging